US Food and Drug Administration Approves First Vaccine to Complete the Rotavirus Immunization Series by 4 Months

被引：0
|
作者：
Nahlen, Dawn Drennan
机构：
来源：
NEWBORN AND INFANT NURSING REVIEWS | 2008年 / 8卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R47 [护理学];
学科分类号：
1011 ;
摘要：
引用
收藏
页码：E33 / E33
页数：1
相关论文
共 50 条
  • [41] Novartis Receives Food and Drug Administration Approval for Flucelvax, the First Cell-Culture Vaccine in United States to Help Protect Against Seasonal Influenza
    不详
    CLINICAL INFECTIOUS DISEASES, 2013, 56 (03) : II - II
  • [42] U.S. Food and Drug Administration Approves Paclitaxel Protein-Bound Particles (Abraxane((R))) in Combination with Gemcitabine as First-Line Treatment of Patients with Metastatic Pancreatic Cancer
    Saif, Muhammad Wasif
    JOURNAL OF THE PANCREAS, 2013, 14 (06): : 686 - 688
  • [43] Competitive fitness of Listeria monocytogenes serotype 1/2a and 4b strains in mixed cultures with and without food in the US Food and Drug Administration enrichment protocol
    Gorski, L
    Flaherty, D
    Mandrell, RE
    APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2006, 72 (01) : 776 - 783
  • [44] Overall survival in patients with breast cancer treated with a CDK 4/6 inhibitor plus fulvestrant: A US Food and Drug Administration pooled analysis.
    Gao, Jennifer J.
    Cheng, Joyce
    Prowell, Tatiana Michelle
    Bloomquist, Erik
    Tang, Shenghui
    Wedam, Suparna B.
    Royce, Melanie E.
    Krol, Danielle
    Osgood, Christy
    Ison, Gwynn
    Sridhara, Rajeshwari
    Pazdur, Richard
    Beaver, Julia A.
    Amiri-Kordestani, Laleh
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [45] Development of a multilayer film for the first US Food and Drug Administration cleared aseptically-produced intravenous solution bags with a short history of key medical device milestones
    Czuba, Len
    JOURNAL OF PLASTIC FILM & SHEETING, 2024, 40 (02) : 134 - 150
  • [46] Applying Regulatory Science to Develop Safe and Effective Medicines for Neonates: Report of the US Food and Drug Administration First Annual Neonatal Scientific Workshop, October 28–29, 2014
    Martin Offringa
    Jonathan M. Davis
    Mark A. Turner
    Robert Ward
    Ralph Bax
    Sam Maldonado
    Vikram Sinha
    Susan K. McCune
    Anne Zajicek
    Daniel K. Benjamin
    Christina Bucci-Rechtweg
    Robert M. Nelson
    Therapeutic Innovation & Regulatory Science, 2015, 49 : 623 - 631
  • [47] Comparative Evaluation of US Food and Drug Administration and Pharmacologically Guided Approaches to Determine the Maximum Recommended Starting Dose for First-in-Human Clinical Trials in Adult Healthy Men
    Imam, Md Tarique
    Venkateshan, S. P.
    Tandon, Monika
    Saha, Nilanjan
    Pillai, K. K.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (12): : 1655 - 1664
  • [48] Combined immunogenicity data for a new DTaP-IPV-Hep B-PRP-T vaccine (Hexaxim™) following primary series administration at 2, 4, 6 months of age in Latin America
    Santos-Lima, Eduardo
    B'Chir, Siham
    Lane, Andrew
    VACCINE, 2013, 31 (09) : 1255 - 1258
  • [49] Applying Regulatory Science to Develop Safe and Effective Medicines for Neonates: Report of the US Food and Drug Administration First Annual Neonatal Scientific Workshop, October 28-29, 2014
    Offringa, Martin
    Davis, Jonathan M.
    Turner, Mark A.
    Ward, Robert
    Bax, Ralph
    Maldonado, Sam
    Sinha, Vikram
    McCune, Susan K.
    Zajicek, Anne
    Benjamin, Daniel K., Jr.
    Bucci-Rechtweg, Christina
    Nelson, Robert M.
    THERAPEUTIC INNOVATION & REGULATORY SCIENCE, 2015, 49 (05) : 623 - 631
  • [50] Use of bevacizumab after US Food and Drug Administration (FDA) approval for first-line metastatic colorectal cancer (mCRC): A Cancer Outcomes Research & Surveillance Consortium (CanCORS) study
    Zafar, Y.
    Grambow, S. C.
    Abbott, D. H.
    Schrag, D.
    Kolimaga, J. T.
    Conner, L. Z.
    Weeks, J. C.
    Provenzale, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
12345